BA at $209.69 enters the final stretch before its October 21 earnings call carrying a curious split: analyst sentiment is the most constructive it has been in years, yet the stock has shed nearly 10% over the past month and is drifting lower on no particular catalyst.
The most striking development in recent weeks is on the analyst side. The Street has moved decisively bullish on Boeing. BNP Paribas executed a full reversal in early August, flipping from Underperform all the way to Outperform with a $300 target — a move that alone shifts the story. Argus Research upgraded to Buy around the same time, and JP Morgan raised its target to $290 while maintaining Overweight. Eighteen analysts now carry a Buy or equivalent, against just five Holds and no Sells. The consensus target sits in the $265–$305 range, implying 25–45% upside from current levels. That gap between where analysts think the stock should trade and where it actually trades is the defining tension heading into Q4. Bulls point to a 6% revenue increase and 10% cash flow jump in the most recent quarter, plus a backlog of over 5,800 aircraft — a demand signal that is hard to argue with. Bears counter that supply chain execution and regulatory complexity make that backlog a liability as much as an asset, and that the company's heavy dependence on narrow-body production leaves it exposed if demand conditions shift.
Positioning in the lending market does nothing to complicate the bull case. Short interest is modest at around 2.1% of the free float — low by any measure — and has edged up only half a percent on the week and 13% over the past month. That monthly increase sounds large in percentage terms, but the starting base is so thin that it adds little aggregate pressure. Borrow is essentially free, with cost-to-borrow running at 0.39% and actually falling over the past month. Availability is extraordinarily loose at more than 6,300% — meaning there are roughly 63 shares available to borrow for every one currently shorted. Short sellers have no meaningful position here, and the infrastructure for a squeeze simply does not exist. The ORTEX short score of 32.7 sits near the middle of its recent range, consistent with a stock that shorts are watching from the sidelines rather than pressing.
Options tell a similarly relaxed story. The put/call ratio is 0.88, fractionally below its 20-day average of 0.89, and the z-score of –0.60 means options traders are marginally more call-tilted than usual — not a defensive posture. Neither the 52-week high of 0.98 nor the low of 0.72 is remotely in play. This is an options market that is largely shrugging, not hedging.
Where the data gets more interesting is in the factor scores. Boeing ranks in the 97th and 98th percentiles on 30-day and 90-day EPS momentum — near the top of the entire investable universe. The earnings surprise score sits at the 93rd percentile. Those are elite readings, and they reflect the dramatic improvement in Boeing's financial trajectory after years of crisis-mode operations. The valuation, however, demands some humility: the P/E is running at 82x and has compressed 25 points over the past 30 days simply because the stock has fallen. EV/EBITDA at 27x is also compressing, down 1.3 points on the month. The 12-month forward EPS growth score ranks in just the 10th percentile — a sign that while the recent quarters have beaten expectations, analysts are not forecasting explosive earnings growth ahead. The price-to-book at 16x adds another layer of premium.
On the institutional side, the holder base is anchored by the usual index giants. BlackRock recently reported 7.7% of shares, adding 1.5 million shares in its latest filing. FMR (Fidelity) holds 6.3%, also a recent incremental buyer. Capital Research added nearly 10 million shares in its most recent period — a meaningful conviction move from one of the largest fundamental managers in the market. No Schedule 13D activists appear on the register; all major 5%-plus holders are passive or semi-passive vehicles. The insider picture is dominated by Form F transactions — tax-withholding on vested equity — rather than open-market buying or selling. The one genuine open-market purchase in recent months came from director Bradley Tilden, who bought 1,370 shares at $218.50 in May. Net insider activity over the past 90 days is flat.
The most recent comparable earnings events are worth noting. The July 28 Q2 report produced only a 1.2% gain on the day but a 12% rally over the following five sessions — suggesting that when Boeing beats, the follow-through has been significantly larger than the initial reaction. That five-day figure is the number to track after October 21.
What to watch between now and that date: whether the stock can close the gap back toward $230 as the month-long drawdown stabilises, and whether short interest continues its slow creep higher — if it approaches 3–4% of the float alongside a softening in that EPS momentum score, the bull thesis begins to carry more friction.
See the live data behind this article on ORTEX.
Open BA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
